HSChapter 30
U.S. imports of corticosteroid hormone medicaments in dosage form (HS 300432) totaled $199.5M in April 2026, traded with 24 countries.
Corticosteroid Hormone Medicaments in Dosage Form imports of $199.5M in April 2026 ran 16% above the year-to-date monthly average of $171.7M.
Last updated: April 2026 dataFinished-dose corticosteroid preparations โ including dedicated lines for dexamethasone (3004320010) and methylprednisolone (3004320040) alongside a broader catch-all (3004320060) โ reflect the clinical breadth of this drug class, which spans anti-inflammatory, immunosuppressive, and critical-care applications. France leads US supply under this heading, with India, Ireland, Canada, and the United Kingdom also significant sources. Dexamethasone's prominence as a COVID-19 treatment elevated supply-chain scrutiny for this specific molecule, and importers should be aware that manufacturing quality issues at foreign facilities have historically triggered FDA import alerts for corticosteroid injectables. All entries require FDA approval of the specific product and facility.
AI-written summary of the official U.S. Census Bureau trade figures on this page โ verify before relying on it.
The US schedule assigns dexamethasone and methylprednisolone their own 10-digit lines because of their commercial volume and regulatory monitoring interest. A product containing dexamethasone as its active corticosteroid should be classified under 3004320010 rather than the residual line. Products containing other corticosteroids (e.g., prednisone, hydrocortisone, betamethasone) that are not specifically named fall under 3004320060. Importers should confirm the active ingredient identity on the certificate of analysis.
Yes. Injectable corticosteroid products, particularly those manufactured at facilities with prior FDA warning letters or import alerts, are subject to enhanced examination. FDA has historically placed sterile injectable manufacturers on import alert for cGMP deficiencies. Importers should review the FDA import alert database for their specific foreign manufacturer before committing to a supply arrangement.
Supplier Network
Get discovered by U.S. importers searching for HS 300432 โ Corticosteroid Hormone Medicaments in Dosage Form. Be the first supplier listed.
Monthly import values over time
| Country | Imports | Exports | Balance |
|---|---|---|---|
| FRANCE | $139.1M | $216K | -$138.9M |
| INDIA | $13.8M | $2.9M | -$10.8M |
| CANADA | $8.4M | $6.0M | -$2.4M |
| UNITED KINGDOM | $10.9M | $86K | -$10.8M |
| IRELAND | $10.1M | $94K | -$10.0M |
HS10 import codes under this HS6 parent. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Duty Collected |
|---|---|---|---|---|
| 3004320060 | MEDICAMENTS CONTAINING CORTICOSTEROID HORMONES ETC | $191.3M | 10.00% | $1K |
| 3004320040 | MEDS CONT CRTICSTROID HRMNS,CONT METHYLPRDNISOLONE | $6.9M | -- | -- |
| 3004320010 | MEDS CONT CORTICOSTEROID HRMNES,CONT DEXAMETHASONE | $1.3M | -- | -- |
| 3004320000 | MEDICAMENTS CONTAINING CORTICOSTEROID HORMONES ETC | $0 | -- | -- |
MEDICAMENTS CONTAINING CORTICOSTEROID HORMONES ETC
MEDS CONT CRTICSTROID HRMNS,CONT METHYLPRDNISOLONE
MEDS CONT CORTICOSTEROID HRMNES,CONT DEXAMETHASONE
MEDICAMENTS CONTAINING CORTICOSTEROID HORMONES ETC
HS10 export codes under this HS6 parent. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3004320000 | MEDICAMENTS CONTAINING CORTICOSTEROID HORMONES ETC | $17.8M |
MEDICAMENTS CONTAINING CORTICOSTEROID HORMONES ETC
126.5K kg
MEDICAMENTS NESOI, MEASURED DOSES, RETAIL PK NESOI
HS 300490
IMMUNOLOGICAL PRODUCTS, IN MEASURED DOESE/RTL SALE
HS 300215
VACCINES FOR HUMAN MEDICINE
HS 300241
HORMONES ETC. (NO ANTIBIOTICS CONTAINED) DOSAGE FM
HS 300439
ANTISERA AND OTHER BLOOD FRACTIONS
HS 300212
IMMUNOLOGICAL PRODUCTS, MIXED, NOT IN MSRED DOSES
HS 300214
| State | Imports | Exports | Balance |
|---|---|---|---|
| Delaware | $138.1M | $52K | -$138.1M |
| Pennsylvania | $16.8M | $452K | -$16.3M |
| Tennessee | $10.4M | $2.6M | -$7.8M |
| Port | Imports | Exports | Balance |
|---|---|---|---|
| NEWARK, NJ | $120.5M | $117K | -$120.4M |
| CHESTER, PA | $34.2M | -- | -$34.2M |
| CHICAGO, IL | $10.2M | $4.7M | -$5.6M |